Article: Genentech Reports 38 Percent Increase in Product Sales for First Quarter.

Business Editors/Health & Medical Writers

20 Percent Increase in Net Income and 21 Percent

Increase in Earnings Per Share, Exclusive of Impact of

Redemption and Change in Accounting

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 12, 2001

Genentech, Inc. (NYSE:DNA) today announced a 20 percent increase in net income and a 21 percent increase in earnings per share(1) driven by a 38 percent increase in product sales for the first quarter of 2001, exclusive of the ongoing impact of the 1999 redemption of Genentech's Special Common Stock and related accounting treatment(2), and the cumulative effect of accounting changes(3)(4). ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!